NeuroPace (NPCE) Stock Chart & Stock Price History $8.92 +0.03 (+0.34%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$9.00 +0.08 (+0.89%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NeuroPace Stock Price Performance The NeuroPace (NPCE) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 24.93%, with a year-to-date return of -20.29%. In the past month, the stock has decreased 13.90%, reflecting recent market activity. As of the latest close, NeuroPace traded at $8.92 with a market cap of $292.58 million and volume of 152,011 shares. Receive NPCE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NeuroPace and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.78%1 Month Performance-13.90%3 Month Performance-28.92%Year-To-Date Performance-20.29%1 Year Performance+24.93% NPCE Stock Chart for Friday, August, 8, 2025 NPCE Chart by TradingView NeuroPace Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/07/2025$8.89$8.92+0.34%$9.12$8.82152,011 shs$292.58 million08/06/2025$8.70$8.89+2.18%$8.92$8.64239,253 shs$291.59 million08/05/2025$8.93$8.70-2.58%$9.01$8.47162,486 shs$285.36 million08/04/2025$8.99$8.93-0.67%$9.13$8.87129,994 shs$294.86 million08/01/2025$8.51$8.99+5.64%$9.06$8.25247,015 shs$294.86 million07/31/2025$8.76$8.51-2.85%$8.78$8.49110,393 shs$279.13 million07/30/2025$8.78$8.76-0.23%$9.09$8.65157,378 shs$287.33 million07/29/2025$8.74$8.78+0.46%$8.88$8.59179,229 shs$287.98 million07/28/2025$8.98$8.74-2.67%$9.00$8.70109,245 shs$286.67 million07/25/2025$9.07$8.98-0.99%$9.13$8.79374,471 shs$294.54 million Get the Latest News and Ratings for NPCE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NeuroPace and its competitors with MarketBeat's FREE daily newsletter. 07/24/2025$9.50$9.07-4.53%$9.45$9.06177,803 shs$297.50 million07/23/2025$9.35$9.50+1.60%$9.61$9.26200,988 shs$311.59 million07/22/2025$9.36$9.35-0.11%$9.46$9.15229,942 shs$306.68 million07/21/2025$9.06$9.36+3.31%$9.40$9.00262,856 shs$307.01 million07/18/2025$9.08$9.06-0.22%$9.36$9.01132,242 shs$297.17 million07/17/2025$9.11$9.08-0.33%$9.41$9.04191,406 shs$297.82 million07/16/2025$9.35$9.11-2.57%$9.43$8.97260,312 shs$298.81 million07/15/2025$9.55$9.35-2.09%$9.58$9.26191,786 shs$306.67 million07/14/2025$9.52$9.55+0.32%$9.64$9.24198,855 shs$313.23 million07/11/2025$10.17$9.52-6.39%$10.27$9.50232,549 shs$312.26 million07/10/2025$10.08$10.17+0.89%$10.39$9.95301,688 shs$333.58 million07/09/2025$10.36$10.08-2.70%$10.58$9.91274,438 shs$330.62 million07/08/2025$10.22$10.36+1.37%$10.38$10.10138,603 shs$339.81 million07/07/2025$10.23$10.22-0.05%$10.60$10.05223,411 shs$335.21 million Related Companies BioLife Solutions Stock Price Chart Tandem Diabetes Care Stock Price Chart Pulse Biosciences Stock Price Chart MiMedx Group Stock Price Chart InMode Stock Price Chart Kestra Medical Technologies Stock Price Chart SiBone Stock Price Chart iRadimed Stock Price Chart Embecta Stock Price Chart Beta Bionics Stock Price Chart Receive NPCE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NeuroPace and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NPCE) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredThe Day Silicon DiesThe Day China Left America's Supercomputers in the Dust In 200 seconds, China's quantum computer accomplish...The Oxford Club | SponsoredThis accelerated income plan is solving American's #1 retirement fearThe #1 fear in retirement today? Running out of money. That’s why income expert Tim Plaehn created a simple...Investors Alley | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroPace, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroPace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
